ArticleBMC medical imaging2025
3DSN-net: dual-tandem attention mechanism interaction network for breast tumor classification.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cross-modal attentive fusion network for tri-modal lesion growth prediction.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundBreast cancer is one of the most prevalent malignancies among women worldwide and remains a major public health concern. Accurate classification of breast tumor subtypes is essential for guiding treatment decisions and improving patient outcomes. However, existing deep learning methods for histopathological image analysis often face limitations in balancing classification accuracy with computational efficiency, while failing to fully exploit the deep semantic features in complex tumor images.
methodsWe developed 3DSN-net, a dual-attention interaction network for multiclass breast tumor classification. The model combines two complementary strategies: (i) spatial–channel attention mechanisms to strengthen the representation of discriminative features, and (ii) deformable convolutional layers to capture fine-grained structural variations in histopathological images. To further improve efficiency, a lightweight attention component was introduced to support stable gradient propagation and multi-scale feature fusion Experimental findings demonstrate that 3DSN-net consistently outperforms competing methods in both accuracy and robustness while maintaining favorable computational efficiency. The model effectively distinguishes benign and malignant tumors as well as multiple subtypes, highlighting the advantages of combining spatial–channel attention with deformable feature modeling. The model was trained and evaluated on two histopathological datasets, BreakHis and BCPSD, and benchmarked against several state-of-the-art CNN and Transformer-based approaches under identical experimental conditions.
resultsExperimental results show that 3DSN-net consistently outperforms baseline CNN and Transformer models, achieving 92%–100% accuracy for benign tumors and 86%–99% for malignant tumors, with error rates below 8%. On average, it improves classification accuracy by 3%–5% and ROC-AUC by 0.02 to 0.04 compared with state-of-the-art methods, while maintaining competitive computational efficiency. By enhancing the interaction between spatial and channel attention mechanisms, the model effectively distinguishes breast cancer subtypes, with only a slight reduction in classification speed on larger datasets due to increased data complexity.
conclusionsThis study presents 3DSN-net as a reliable and effective framework for breast tumor classification from histopathological images. Beyond methodological improvements, the enhanced diagnostic performance has direct clinical implications, offering potential to reduce misclassification, assist pathologists in decision-making, and improve patient outcomes. The approach can also be extended to other medical imaging tasks. Future work will focus on optimizing computational efficiency and validating generalizability across larger, multi-center datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.